Hydralazine
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Hydralazine (opens in a new tab)Original source URL: https://globalrph.com/dilution/hydralazine/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/hydralazine/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:46:33.974212+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- b72590a88fb8565a14e119f7dbffc9bb3d308e69a0243366a330fa418381b69f
- Original response SHA-256
- 50ff0d35532f9e3511fc0a77d50cbc3b70d95dce89e34d107328d4c34635c456
- Source body SHA-256
- 89455951a85e195c27e2c345a9ca8bffbeb6da67078dbf2a828a82c9744736bd
HYDRALAZINE |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| [0 to 20 mg] [50 ml] [30 min] [21 to 40 mg] [100 ml] [30 min] [>40 mg] [250 ml] [60 min or longer] Monitor BP q5min during initial infusion. |
Stability / Miscellaneous |
| Manufacturer recommends IM or IV push.
Usual dosage: 10 to 40 mg IV q4-6h prn. May be given q20-30 minutes (until adequate response) for the treatment of severe hypertension. IV push (rate): 10 mg/min. Label: Do not refrigerate. Stability: 24 hours room temperature. DOSAGE AND ADMINISTRATION Certain patients (especially those with marked renal damage) may require a lower dose. Blood pressure should be checked frequently. It may begin to fall within a few minutes after injection, with the average maximal decrease occurring in 10-80 minutes. In cases where there has been increased intracranial pressure, lowering the blood pressure may increase cerebral ischemia. Most patients can be transferred to oral hydralazine hydrochloride within 24-48 hours. The product should be used immediately after the vial is opened. It should not be added to infusion solutions. Hydralazine hydrochloride injection may discolor upon contact with metal; discolored solutions should be discarded. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Source: [package insert] |